S&P/ASX 200 Stages a Comeback: Banks Hold Their Ground, Healthcare and Materials Feel the Squeeze

It was one of those Fridays that keeps you on your toes. The S&P/ASX 200 looked set for a bloodbath in early trading, dipping below 8,905, but buyers stepped in and we closed the session at 8,960.60. That’s a drop of just 0.14 per cent. Given where we started the day, I’d call that a win.

We’ve seen this film before. The local market snapped a three-session winning streak, but the fact that we halved those morning losses tells you everything about the underlying support. The volatility we’re seeing is purely external. But let’s get into the nitty-gritty, because the sectors are telling very different stories right now.

The Big Four hold the line

If you want to know why the ASX wasn’t completely wiped out today, look no further than the banking sector. The S&P/ASX 200 Financials [XFJ] proved exactly why it’s the anchor of this market. While tech and miners were getting hammered, the money printers just kept humming.

Specifically, the S&P/ASX 200 BANKS [XBK] index had a cracker of a session. National Australia Bank, Westpac, and CBA all finished in the green—modest gains, sure, up between 0.1 and 0.2 per cent, but green is gold on a red day. ANZ was the odd one out, dipping a fraction, but the resilience was unmistakable. Investors are parking their cash in financials as a safe harbour, and honestly, with dividend season looming, I don’t blame them.

• Defensive flows: Money rotated out of growth stocks and straight into the Big Four.
• Volume: Trading volume in financials was well above the monthly average.
• Outlook: With rate expectations settling, the net interest margin outlook is stabilising.

Healthcare takes a hit, but value hunters are circling

It wasn’t such a pretty picture for the med-techs and biotechs. The S&P/ASX 200 Health Care [XHJ] has had a shocking run in 2026, and today added to the pain. The index is now down nearly 17 per cent year to date. That’s a brutal correction for a sector we usually call defensive.

But here’s where it gets interesting. In the middle of the sell-off, I was watching Telix Pharmaceuticals. This stock has been on a rollercoaster. Down 48 per cent over the last year, but up 55 per cent since mid-February. Today, it was one of the top gainers on the entire ASX 200, jumping nearly 7 per cent to $14.57. Some local brokers are still calling a $19 price target. That’s a 39 per cent upside from here.

Same story with Mayne Pharma. The stock is down 32 per cent on the year, but the company came out fighting today, telling the market that new tariff noise will have "no material impact" on FY27 earnings. When you see a stock trading at $2.16 with an average analyst target of $5.75, you have to sit up and take notice. The XHJ might be bleeding, but the vultures are circling for a reason.

Materials feel the weight of the world

If healthcare was bad, the miners were worse. The S&P/ASX 200 Materials [XMJ] got absolutely belted. We’re talking a sea of red from BHP down to the small caps. BHP edged down 0.4 per cent, but the real pain was in the mid-tiers. Fortescue dropped nearly 2 per cent, and Mineral Resources wasn’t far behind.

It’s the same old story—commodity prices are jittery, and global growth fears are spooking the market. The XMJ has been incredibly volatile all quarter, and today’s price action suggests institutional investors are still reducing risk. Champion Iron lost over 4 per cent, and the gold miners, which usually act as a hedge, were also in the red. Evolution Mining lost 2 per cent. When gold doesn’t work on a risk-off day, you know sentiment is fragile.

Looking at the broader market, the tech sell-off added to the misery. Xero slipped almost 3 per cent, and WiseTech dropped more than 2 per cent. Even the oil stocks, which should be flying given where crude is, were mostly lower. Woodside and Santos both declined.

So, where does that leave us? The S&P/ASX 200 is showing incredible grit. We bounced hard off the intraday lows. The banks are holding the fort, and while healthcare and materials are under the pump, the value propositions are starting to scream. It’s a stock picker’s market, pure and simple. Don’t just buy the index; buy the stories that make sense.